Yuan, H., Kehm, R. D., Daaboul, J. M., Lloyd, S. E., McDonald, J. A., Mu, L., Tehranifar, P., Zhang, K., Terry, M. B., & Yang, W. (2024). Cancer incidence trends in New York State and associations with common population-level exposures 2010–2018: an ecological study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-56634-w

Lee, K. T., Gonzalez, B. D., Geiss, C., Fulton, H. J., Charles, D., Vadaparampil, S. T., Henry, N. L., Jim, H. S. L., Hershman, D. L., Tworoger, S. S., & Gwede, C. K. (2024). Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01574-7

Wang, Z., Yang, X., Chen, D., Liu, Y., Li, Z., Duan, S., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. (2024). GAS41 modulates ferroptosis by anchoring NRF2 on chromatin. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-46857-w

Nolan, N. D., Cui, X., Robbings, B. M., Demirkol, A., Pandey, K., Wu, W.-H., Hu, H. F., Jenny, L. A., Lin, C.-S., Hass, D. T., Du, J., Hurley, J. B., & Tsang, S. H. (2024). CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa. Cell Reports Medicine, 5(4), 101459. https://doi.org/10.1016/j.xcrm.2024.101459

Damoci, C. B., Merrill, J. R., Sun, Y., Lyons, S. K., & Olive, K. P. (2024). Addressing Biological Questions with Preclinical Cancer Imaging. Cold Spring Harbor Perspectives in Medicine, a041378. https://doi.org/10.1101/cshperspect.a041378

Fojo, T., LaRose, M., & Bates, S. E. (2024). The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype. The Oncologist, 29(4), 275–277. https://doi.org/10.1093/oncolo/oyae042

Tzaridis, T., & Wechsler-Reya, R. J. (2024). Just a spoonful of metformin helps the medicine go down. Journal of Clinical Investigation, 134(6). https://doi.org/10.1172/jci179144

Arriaga, J. M., Ronaldson-Bouchard, K., Picech, F., Nunes de Almeida, F., Afari, S., Chhouri, H., Vunjak-Novakovic, G., & Abate-Shen, C. (2024). In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. Oncogene, 43(17), 1303–1315. https://doi.org/10.1038/s41388-024-02995-5

Ben-Ami, R., Wang, Q.-L., Zhang, J., Supplee, J. G., Fahrmann, J. F., Lehmann-Werman, R., Brais, L. K., Nowak, J., Yuan, C., Loftus, M., Babic, A., Irajizad, E., Davidi, T., Zick, A., Hubert, A., Neiman, D., Piyanzin, S., Gal-Rosenberg, O., Horn, A., … Wolpin, B. M. (2023). Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut, gutjnl-2023-331074. https://doi.org/10.1136/gutjnl-2023-331074

Mohan, M., Monge, J., Shah, N., Luan, D., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al-Hadidi, S., Cooper, D., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2024). Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood Cancer Journal, 14(1). https://doi.org/10.1038/s41408-024-01003-z

Liu, Y., Wang, Y., Feng, H., Ma, L., & Liu, Y. (2024). PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1344058

Mülder, D. T., Hahn, A. I., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., Murphy, J. D., Gutiérrez-Torres, D. S., Zauber, A. G., O’Mahony, J. F., Camargo, M. C., Ladabaum, U., Yeh, J. M., Hur, C., Lansdorp-Vogelaar, I., Meester, R., & Laszkowska, M. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 22(8), 1605-1617.e46. https://doi.org/10.1016/j.cgh.2024.02.023

Huang, Y., Chan, S. J., Wright, J. D., Kuo, J. H., McManus, C. M., Lee, J. A., & Kuo, E. J. (2024). Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States. Thyroid®, 34(3), 388–398. https://doi.org/10.1089/thy.2023.0651

Wang, K., Du, R., Myall, N. J., Lewis, W. E., Uy, N., Hong, L., Skoulidis, F., Byers, L. A., Tsao, A., Cascone, T., Pozadzides, J., Tu, J., Negrao, M. V., Gibbons, D. L., Park, K., Rinsurongkawong, W., Lee, J. J., Gandara, D., Behl, D., … Le, X. (2024). Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. Journal of Thoracic Oncology, 19(3), 500–506. https://doi.org/10.1016/j.jtho.2023.11.020

Yang, W., & Shaman, J. (2024). Reconciling the efficacy and effectiveness of masking on epidemic outcomes. Journal of The Royal Society Interface, 21(212). https://doi.org/10.1098/rsif.2023.0666

Solfisburg, Q. S., Baldini, F., Baldwin-Hunter, B., Austin, G. I., Lee, H. H., Park, H., Freedberg, D. E., Lightdale, C. J., Korem, T., & Abrams, J. A. (2023). The Salivary Microbiome and Predicted Metabolite Production Are Associated with Barrett’s Esophagus and High-Grade Dysplasia or Adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention, 33(3), 371–380. https://doi.org/10.1158/1055-9965.epi-23-0652

Katsushima, K., Joshi, K., Yuan, M., Romero, B., Batish, M., Stapleton, S., Jallo, G., Kolanthai, E., Seal, S., Saulnier, O., Taylor, M. D., Wechsler-Reya, R. J., Eberhart, C. G., & Perera, R. J. (2024). A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma. Cell Reports, 43(3), 113938. https://doi.org/10.1016/j.celrep.2024.113938

Mellgard, G., Gilligan, M., Cliff, E. R. S., Bhutani, D., Mohyuddin, G. R., Eisenberger, A., Lentzsch, S., & Chakraborty, R. (2024). Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma. HemaSphere, 8(3). Portico. https://doi.org/10.1002/hem3.61

Su, Z., Liu, Y., Wang, L., & Gu, W. (2024). Regulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis. Genes & Diseases, 101254. https://doi.org/10.1016/j.gendis.2024.101254

Hu, X., Bukhari, S. M., Tymm, C., Adam, K., Lerrer, S., Henick, B. S., Winchester, R. J., & Mor, A. (2024). Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity. Journal for ImmunoTherapy of Cancer, 12(3), e008482. https://doi.org/10.1136/jitc-2023-008482

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients. (2024). The American Journal of Managed Care, 30(3), 114–117. Portico. https://doi.org/10.37765/ajmc.2024.89512

Hammons, L., Szabo, A., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Dhakal, B., Al Hadidi, S., Radhakrishnan, S. V., Narra, R., Bhutani, D., Thanendrarajan, S., Janz, S., Zangari, M., Lentzsch, S., Van Rhee, F., Crescencio, J. C. R., D’Souza, A., Chakraborty, R., Mohan, M., & Schinke, C. (2023). The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. Haematologica, 109(3), 906–914. https://doi.org/10.3324/haematol.2023.283590

Dai, E., Chen, X., Linkermann, A., Jiang, X., Kang, R., Kagan, V. E., Bayir, H., Yang, W. S., Garcia-Saez, A. J., Ioannou, M. S., Janowitz, T., Ran, Q., Gu, W., Gan, B., Krysko, D. V., Zhu, X., Wang, J., Krautwald, S., Toyokuni, S., … Tang, D. (2024). A guideline on the molecular ecosystem regulating ferroptosis. Nature Cell Biology. https://doi.org/10.1038/s41556-024-01360-8

Brown, J. R., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, H., & Tedeschi, A. (2024). Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. Haematologica. https://doi.org/10.3324/haematol.2023.283846

Zorko, N. A., Makovec, A., Elliott, A., Kellen, S., Lozada, J. R., Arafa, A. T., Felices, M., Shackelford, M., Barata, P., Zakharia, Y., Narayan, V., Stein, M. N., Zarrabi, K. K., Patniak, A., Bilen, M. A., Radovich, M., Sledge, G., El-Deiry, W. S., Heath, E. I., … Antonarakis, E. S. (2024). Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-024-00797-0

Cheng, X., Henick, B. S., & Cheng, K. (2024). Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles. ACS Nano, 18(9), 6748–6765. https://doi.org/10.1021/acsnano.3c06462

Chen, F., Tang, C., Yang, F., Ekpenyong, A., Qin, R., Xie, J., Momen-Heravi, F., Saba, N. F., & Teng, Y. (2024). HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science Advances, 10(8). https://doi.org/10.1126/sciadv.adk3663

Beauchemin, M. P., Ji, L., Williams, A. M., Nightingale, C. L., Dressler, E. V., Salsman, J. M., Santacroce, S. J., Freyer, D. R., Roth, M. E., & Parsons, S. K. (2024). Defining Practice Capacity for Cancer Care Delivery to Adolescents and Young Adults in the Community Setting: 2022 Landscape Assessment Results. Journal of Adolescent and Young Adult Oncology, 13(3), 557–563. https://doi.org/10.1089/jayao.2023.0177

Qiu, B., Zandkarimi, F., Bezjian, C. T., Reznik, E., Soni, R. K., Gu, W., Jiang, X., & Stockwell, B. R. (2024). Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell, 187(5), 1177-1190.e18. https://doi.org/10.1016/j.cell.2024.01.030

Chen, J., Terry, M. B., Dalerba, P., Hur, C., Hu, J., & Yang, W. (2024). Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States. International Journal of Cancer, 154(11), 1930–1939. Portico. https://doi.org/10.1002/ijc.34887

Hasselluhn, M. C., Decker-Farrell, A. R., Vlahos, L., Thomas, D. H., Curiel-Garcia, A., Maurer, H. C., Wasko, U. N., Tomassoni, L., Sastra, S. A., Palermo, C. F., Dalton, T. C., Ma, A., Li, F., Tolosa, E. J., Hibshoosh, H., Fernandez-Zapico, M. E., Muir, A., Califano, A., & Olive, K. P. (2023). Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Cancer Discovery, 14(2), 348–361. https://doi.org/10.1158/2159-8290.cd-23-0240

Montoya, S., Bourcier, J., Noviski, M., Lu, H., Thompson, M. C., Chirino, A., Jahn, J., Sondhi, A. K., Gajewski, S., Tan, Y. S. (May), Yung, S., Urban, A., Wang, E., Han, C., Mi, X., Kim, W. J., Sievers, Q., Auger, P., Bousquet, H., … Taylor, J. (2024). Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science, 383(6682). https://doi.org/10.1126/science.adi5798

Vincent, R. L., Li, F., Ballister, E. R., Arpaia, N., & Danino, T. (2024). Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells. Journal of Visualized Experiments, 204. https://doi.org/10.3791/65887

Savage, T. M., Fortson, K. T., de los Santos-Alexis, K., Oliveras-Alsina, A., Rouanne, M., Rae, S. S., Gamarra, J. R., Shayya, H., Kornberg, A., Cavero, R., Li, F., Han, A., Haeusler, R. A., Adam, J., Schwabe, R. F., & Arpaia, N. (2024). Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis. Immunity, 57(2), 303-318.e6. https://doi.org/10.1016/j.immuni.2024.01.009

Yang, X., Wang, Z., Samovich, S. N., Kapralov, A. A., Amoscato, A. A., Tyurin, V. A., Dar, H. H., Li, Z., Duan, S., Kon, N., Chen, D., Tycko, B., Zhang, Z., Jiang, X., Bayir, H., Stockwell, B. R., Kagan, V. E., & Gu, W. (2024). PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression. Cell Metabolism, 36(4), 762-777.e9. https://doi.org/10.1016/j.cmet.2024.01.006

Mellgard, G. S., Fojo, T., & Bates, S. E. (2024). Lessons from withdrawn accelerated approvals in oncology. Nature Cancer, 5(2), 211–215. https://doi.org/10.1038/s43018-023-00696-8

Kehm, R. D., Knight, J. A., Houghton, L. C., McDonald, J. A., Schwartz, L. A., Goldberg, M., Chung, W. K., Frost, C. J., Wei, Y., Bradbury, A. R., Keegan, T. H. M., Daly, M. B., Buys, S. S., Andrulis, I. L., John, E. M., & Terry, M. B. (2024). Childhood physical activity and pubertal timing: findings from the LEGACY girls study. International Journal of Epidemiology, 53(1). https://doi.org/10.1093/ije/dyad193

Masuda, M. Y., Pyon, G. C., Luo, H., LeSuer, W. E., Putikova, A., Dao, A., Ortiz, D. R., Schulze, A. R., Fritz, N., Kobayashi, T., Iijima, K., Klein-Szanto, A. J., Shimonosono, M., Flashner, S., Morimoto, M., Pai, R. K., Rank, M. A., Nakagawa, H., Kita, H., … Doyle, A. D. (2024). Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13. Journal of Allergy and Clinical Immunology, 153(5), 1355–1368. https://doi.org/10.1016/j.jaci.2024.01.017

Leuzzi, G., Vasciaveo, A., Taglialatela, A., Chen, X., Firestone, T. M., Hickman, A. R., Mao, W., Thakar, T., Vaitsiankova, A., Huang, J.-W., Cuella-Martin, R., Hayward, S. B., Kesner, J. S., Ghasemzadeh, A., Nambiar, T. S., Ho, P., Rialdi, A., Hebrard, M., Li, Y., … Ciccia, A. (2024). SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion. Cell, 187(4), 861-881.e32. https://doi.org/10.1016/j.cell.2024.01.008

Rogava, M., Aprati, T. J., Chi, W.-Y., Melms, J. C., Hug, C., Davis, S. H., Earlie, E. M., Chung, C., Deshmukh, S. K., Wu, S., Sledge, G., Tang, S., Ho, P., Amin, A. D., Caprio, L., Gurjao, C., Tagore, S., Ngo, B., Lee, M. J., … Izar, B. (2024). Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation. Nature Cancer, 5(3), 433–447. https://doi.org/10.1038/s43018-023-00704-x

Bloomhardt, H., Rubin, M., Xue, Y., Jin, Z., Masino, L., Seidel, D., Hijiya, N., & Beauchemin, M. (2024). Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy‐induced nausea and vomiting management: Experiences at an academic medical center. Pediatric Blood & Cancer, 71(4). Portico. https://doi.org/10.1002/pbc.30883

Yoon, J. Y., Lim, F., Shah, S. C., Rubenstein, J. H., Abrams, J. A., Katzka, D., Inadomi, J., Kim, M. K., & Hur, C. (2024). Endoscopic Surveillance of Intestinal Metaplasia of the Esophagogastric Junction: A Decision Modeling Analysis. American Journal of Gastroenterology, 119(7), 1289–1297. https://doi.org/10.14309/ajg.0000000000002672

Neupane, K., Fortuna, G. G., Dahal, R., Schmidt, T., Fonseca, R., Chakraborty, R., Koehn, K. A., Mohan, M., Mian, H., Costa, L. J., Sborov, D., & Mohyuddin, G. R. (2024). Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood Cancer Journal, 14(1). https://doi.org/10.1038/s41408-024-00985-0

Fahmy, L. M., Schreidah, C. M., McDonnell, D. E., Carvajal, R. D., Magro, C. M., & Geskin, L. J. (2024). Cutaneous type IV hypersensitivity reaction following tebentafusp treatment for uveal melanoma. Dermatology Online Journal, 29(6). https://doi.org/10.5070/d329662993

Straube, J., Bukhari, S., Lerrer, S., Winchester, R. J., Gartshteyn, Y., Henick, B. S., Dragovich, M. A., & Mor, A. (2024). PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis. Arthritis Research & Therapy, 26(1). https://doi.org/10.1186/s13075-023-03259-5

Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., Taylor, S. R., Jang, Y., Sivan, A., Rhee, K., Saleh, A. A., Chien, T., Zandkarimi, F., Lia, I., Lannagan, T. R. M., Wang, T., Wright, J. A., Kobayashi, H., Ng, J. Q., … Danino, T. (2024). Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-44776-4

Tchouta, L. N., & Schrope, B. A. (2023). Evolving Technique for Puestow-Type Procedure for Chronic Pancreatitis: The Combined Roux-en-Y Proximal End-to-Side and Distal Longitudinal Pancreatojejunostomy. American Journal of Case Reports, 25. https://doi.org/10.12659/ajcr.942066

Dunbar, K. J., Wong, K. K., & Rustgi, A. K. (2024). Cancer-Associated Fibroblasts in Esophageal Cancer. Cellular and Molecular Gastroenterology and Hepatology, 17(5), 687–695. https://doi.org/10.1016/j.jcmgh.2024.01.008

Yanagihara, T. K., Tepper, J. E., Moon, A. M., Barry, A., Molla, M., Seong, J., Torres, F., Apisarnthanarax, S., Buckstein, M., Cardenes, H., Chang, D. T., Feng, M., Guha, C., Hallemeier, C. L., Hawkins, M. A., Hoyer, M., Iwata, H., Jabbour, S. K., Kachnic, L., … Dawson, L. A. (2024). Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Practical Radiation Oncology, 14(2), 134–145. https://doi.org/10.1016/j.prro.2023.08.016

Huang, X., Balmer, S., Lyu, C., Xiang, Y., Malik, V., Wang, H., Zhang, Y., Cai, B., Xie, W., Hadjantonakis, A.-K., Zhou, H., & Wang, J. (2024). ZFP281 controls transcriptional and epigenetic changes promoting mouse pluripotent state transitions via DNMT3 and TET1. Developmental Cell, 59(4), 465-481.e6. https://doi.org/10.1016/j.devcel.2023.12.018